These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 25116076)

  • 1. Exploring the influence of the protein environment on metal-binding pharmacophores.
    Martin DP; Blachly PG; McCammon JA; Cohen SM
    J Med Chem; 2014 Aug; 57(16):7126-35. PubMed ID: 25116076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of donor atom identity on metal-binding pharmacophore coordination.
    Dick BL; Patel A; McCammon JA; Cohen SM
    J Biol Inorg Chem; 2017 Jun; 22(4):605-613. PubMed ID: 28389830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 'Unconventional' coordination chemistry by metal chelating fragments in a metalloprotein active site.
    Martin DP; Blachly PG; Marts AR; Woodruff TM; de Oliveira CA; McCammon JA; Tierney DL; Cohen SM
    J Am Chem Soc; 2014 Apr; 136(14):5400-6. PubMed ID: 24635441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of binding modes and affinities of 4-substituted-2,3,5,6-tetrafluorobenzenesulfonamide inhibitors to the carbonic anhydrase receptor by docking and ONIOM calculations.
    Samanta PN; Das KK
    J Mol Graph Model; 2016 Jan; 63():38-48. PubMed ID: 26619075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbonic anhydrase inhibitors. X-ray crystal studies of the carbonic anhydrase II-trithiocarbonate adduct--an inhibitor mimicking the sulfonamide and urea binding to the enzyme.
    Temperini C; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2010 Jan; 20(2):474-8. PubMed ID: 20005709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleophile recognition as an alternative inhibition mode for benzoic acid based carbonic anhydrase inhibitors.
    Martin DP; Cohen SM
    Chem Commun (Camb); 2012 May; 48(43):5259-61. PubMed ID: 22531842
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Prosser KE; Kohlbrand AJ; Seo H; Kalaj M; Cohen SM
    Chem Commun (Camb); 2021 May; 57(40):4934-4937. PubMed ID: 33870988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbonic anhydrase inhibitors: X-ray crystal structure of a benzenesulfonamide strong CA II and CA IX inhibitor bearing a pentafluorophenylaminothioureido tail in complex with isozyme II.
    Di Fiore A; De Simone G; Menchise V; Pedone C; Casini A; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2005 Apr; 15(7):1937-42. PubMed ID: 15780637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective hydrophobic pocket binding observed within the carbonic anhydrase II active site accommodate different 4-substituted-ureido-benzenesulfonamides and correlate to inhibitor potency.
    Pacchiano F; Aggarwal M; Avvaru BS; Robbins AH; Scozzafava A; McKenna R; Supuran CT
    Chem Commun (Camb); 2010 Nov; 46(44):8371-3. PubMed ID: 20922253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and docking studies of new 1,3,4-thiadiazole-2-thione derivatives with carbonic anhydrase inhibitory activity.
    Abdel-Hamid MK; Abdel-Hafez AA; El-Koussi NA; Mahfouz NM; Innocenti A; Supuran CT
    Bioorg Med Chem; 2007 Nov; 15(22):6975-84. PubMed ID: 17822907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding affinity of substituted ureido-benzenesulfonamide ligands to the carbonic anhydrase receptor: a theoretical study of enzyme inhibition.
    Sahu C; Sen K; Pakhira S; Mondal B; Das AK
    J Comput Chem; 2013 Aug; 34(22):1907-16. PubMed ID: 23712937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metalloprotein-inhibitor binding: human carbonic anhydrase II as a model for probing metal-ligand interactions in a metalloprotein active site.
    Martin DP; Hann ZS; Cohen SM
    Inorg Chem; 2013 Nov; 52(21):12207-15. PubMed ID: 23706138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-Substituted-(1,2,3-triazol-4-yl)thiophene-2-sulfonamides strongly inhibit human carbonic anhydrases I, II, IX and XII: solution and X-ray crystallographic studies.
    Leitans J; Sprudza A; Tanc M; Vozny I; Zalubovskis R; Tars K; Supuran CT
    Bioorg Med Chem; 2013 Sep; 21(17):5130-8. PubMed ID: 23859774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Out of the active site binding pocket for carbonic anhydrase inhibitors.
    D'Ambrosio K; Carradori S; Monti SM; Buonanno M; Secci D; Vullo D; Supuran CT; De Simone G
    Chem Commun (Camb); 2015; 51(2):302-5. PubMed ID: 25407638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of different thio-scaffolds bearing sulfonamide with subnanomolar carbonic anhydrase II and IX inhibitory properties and X-ray investigations for their inhibitory mechanism.
    Angeli A; Tanini D; Capperucci A; Malevolti G; Turco F; Ferraroni M; Supuran CT
    Bioorg Chem; 2018 Dec; 81():642-648. PubMed ID: 30253337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbonic anhydrase II-induced selection of inhibitors from a dynamic combinatorial library of Schiff's bases.
    Nasr G; Petit E; Supuran CT; Winum JY; Barboiu M
    Bioorg Med Chem Lett; 2009 Nov; 19(21):6014-7. PubMed ID: 19796939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectroscopic and molecular modeling studies on binding of dorzolamide to bovine and human carbonic anhydrase II.
    Bijari N; Ghobadi S; Mahdiuni H; Khodarahmi R; Ghadami SA
    Int J Biol Macromol; 2015 Sep; 80():189-99. PubMed ID: 26093313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isosteres of hydroxypyridinethione as drug-like pharmacophores for metalloenzyme inhibition.
    Adamek RN; Credille CV; Dick BL; Cohen SM
    J Biol Inorg Chem; 2018 Oct; 23(7):1129-1138. PubMed ID: 30003339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of 3,4-Dihydroisoquinoline-2(1H)-sulfonamides as potent carbonic anhydrase inhibitors: synthesis, biological evaluation, and enzyme--ligand X-ray studies.
    Gitto R; Agnello S; Ferro S; De Luca L; Vullo D; Brynda J; Mader P; Supuran CT; Chimirri A
    J Med Chem; 2010 Mar; 53(6):2401-8. PubMed ID: 20170095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein crystal structures with ferrocene and ruthenocene-based enzyme inhibitors.
    Salmon AJ; Williams ML; Hofmann A; Poulsen SA
    Chem Commun (Camb); 2012 Feb; 48(17):2328-30. PubMed ID: 22258283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.